SCHEMBL23016133

SCHEMBL23016133

c1cc(-c2ccc3cc(-c4ccc5nc(-c6ccc(-c7ccc8ccc9cccnc9c8n7)cc6)ccc5c4)ccc3n2)c2cnccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 3/20 0.42
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP1A2 P05177 1/20 0.38
AR P10275 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPK10 P53779 3/20 0.38
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
HTR2C P28335 2/20 0.36
PIK3CA P42336 1/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22282120 0.97 TNF (0.40) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL23016129 0.97 TNF (0.41) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL23016293 0.94 TNF (0.44) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL24475592 0.94 TNF (0.39) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL22281881 0.92 TNF (0.43) TNFNPC1RAB9ACYP3A4CYP2D6
SCHEMBL23016130 0.92 TNF (0.41) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL24475371 0.92 TNF (0.41) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL23016128 0.91 IKBKE (0.41) NPC1RAB9APOLBCYP3A4CYP2D6
SCHEMBL23016134 0.91 TNF (0.43) TNFNPC1RAB9APOLBCYP3A4
SCHEMBL23016292 0.89 TNF (0.41) TNFNPC1RAB9APOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10930857-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10930857-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA TNF 1871/4885NPC1 4299/4885RAB9A 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.